ARTICLE | Politics & Policy
BIO appoints Levin chairman
June 4, 2019 7:40 PM UTC
BIO elected as its new chairman Jeremy Levin, who is chairman and CEO of Ovid Therapeutics Inc. (NASDAQ:OVID). He succeeds John Maraganore, CEO of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY).
The Biotechnology Innovation Organization elected Ted Love as chair of its emerging companies section governing board and Hugh Welsh as chair of the industrial and environmental section governing board. Love is president and CEO of Global Blood Therapeutics Inc. (NASDAQ:GBT) and Welsh is general counsel and president of the North America unit of Royal DSM N.V. (Euronext:DSM). ...